Paragon Gene Therapy

Paragon Gene Therapy is a company that focuses on transformative technologies, including gene therapies, vaccines, and oncology immunotherapies. It provides biopharmaceuticals with a range of services covering analytical development, cell line construction, drug substance and drug product manufacturing, etc. The company operates facilities that are designed for the production of proteins, monoclonal antibodies, recombinant vaccines, and virus-like particles.
TypeSubsidiary
Parent CompanyCatalent
Founded1990
Websiteparagonbioservices.com
Cybersecurity ratingAMore
Paragon Gene Therapy was founded in 1990

Viewing summary data as a guest

Sign up for free to see all data

Paragon Gene Therapy Financials and Metrics

Summary Metrics

Founding Date

1990

Total Funding

$20 m

Investors

In total, Paragon Gene Therapy had raised $20 m. Paragon Gene Therapy is a subsidiary of Catalent

Paragon Gene Therapy Cybersecurity Score

Cybersecurity ratingPremium dataset

A

91/100

SecurityScorecard logo

Paragon Gene Therapy Online and Social Media Presence

Embed Graph

Paragon Gene Therapy Blogs

Innovations in ADC Technologies

Summary: There has been a lot of activity in the ADC market in the past 12-18 months in terms of licensing deals, acquisitions and investments. It’s likely no coincidence that this... The post Innovations in ADC Technologies appeared first on Catalent Biologics.

Manufacturing Innovation Across New Modalities

Summary: The successful outcomes delivered by cell and gene therapies coupled with emergence of modalities across nucleic acid therapeutics and microbiomes pose the next challenge for innovators to make these new modalities... The post Manufacturing Innovation Across New Modalities appeared first on…

Navigating the Path to the Clinic and Beyond for Gene Therapies

Date: February 2, 2021 The post Navigating the Path to the Clinic and Beyond for Gene Therapies appeared first on Catalent Biologics.

Early Phase Biologic Development: Upstream and Downstream Processes Considerations

Date: February 23, 2021 The post Early Phase Biologic Development: Upstream and Downstream Processes Considerations appeared first on Catalent Biologics.

Women in Biopharma Awards 2020

Summary: Gwen Green, VP of Commercial Excellence at Catalent, and Endpoints News editors highlight the top 20 women in biopharma who have made it to the upper echelons of the drug development business in this on-demand webinar. The post Women in Biopharma Awards 2020 appeared first on Catalent Biolo…

Fireside Chat with John Chiminski – JPMorgan Week 2021

Date: January 11, 2021 The post Fireside Chat with John Chiminski – JPMorgan Week 2021 appeared first on Catalent Biologics.
Show more

Paragon Gene Therapy Frequently Asked Questions

  • When was Paragon Gene Therapy founded?

    Paragon Gene Therapy was founded in 1990.

  • How many employees does Paragon Gene Therapy have?

    Paragon Gene Therapy has 241 employees.

  • Who are Paragon Gene Therapy competitors?

    Competitors of Paragon Gene Therapy include Epify, Serotiny and Sagetis Biotech.